Based on the analysis of TCGA and CGGA GBM databases, it was found that the TGF-β signaling pathway was enriched in the SECTM1 high-expression group, and TGF-β1 was positively correlated with SECTM1. The gene discussed is SECTM1; the disease is glioblastoma.